Signe Lykke Nielsen

Signe Lykke Nielsen

Biomedical Laboratory Scientist


Publication year:
All
1 - 3 out of 3Page size: 10
  1. 2016
  2. Published

    Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines

    Jandu, H., Aluzaité, K., Fogh, L., Thrane, S. W., Noer, J. B., Proszek, J., Nguyen Do, K., Hansen, S. N., Damsgaard-Hansen, B., Nielsen, S. L., Stougaard, M., Knudsen, B. R., Moreira, J., Hamerlik, P., Gajjar, M., Smid, M., Martens, J., Foekens, J., Pommier, Y., Brünner, N. & 2 others, Rasmussen, A. S. & Stenvang, Jan, 22 Jan 2016, In: B M C Cancer. 16, 13 p., 34.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification

    Tarpgaard, L. S., Qvortrup, C., Nygård, S. B., Nielsen, Signe Lykke, Andersen, D. R., Jensen, N. F., Stenvang, Jan, Detlefsen, S., Brünner, N. & Pfeiffer, P., 2016, In: B M C Cancer. 16, 5 p., 91.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    DNA Topoisomerase I Gene Copy Number and mRNA Expression Assessed as Predictive Biomarkers for Adjuvant Irinotecan in Stage II/III Colon Cancer

    Nygård, S. B., Vainer, B., Nielsen, Signe Lykke, Bosman, F. T., Tejpar, S., Roth, A., Delorenzi, M., Brunner, N. & Budinska, E., 2016, In: Clinical Cancer Research. 22, 7, p. 1621-1631

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 37447272